Cost-effectiveness of HIV/AIDS interventions in Africa: a systematic review of the evidence
The LancetPublished 1 May 2002
Andrew Creese, Katherine Floyd, Anita Alban, Lorna Guinness
Citations400
SJR quartileQ1
SJR score12.11
SNIP22.72
Generate an AI Snapshot to get a quick, structured summary of this paper.
Study Snapshot
ObjectiveStudy objective
MethodsResearch methodology
PopulationPopulation studied
Sample sizeSample sizes
OutcomesStudy outcomes here
ResultsStudy results comes here
LimitationsResearch study limitations comes here
A concise AI-generated summary of the paper will appear here once you click Generate AI Snapshot.
TL;DR
A strong economic case exists for prioritisation of preventive interventions and tuberculosis treatment and where potentially exclusive alternatives exist, cost-effectiveness analysis points to an intervention that offers the best value for money.
Abstract
A strong economic case exists for prioritisation of preventive interventions and tuberculosis treatment. Where potentially exclusive alternatives exist, cost-effectiveness analysis points to an intervention that offers the best value for money. Cost-effectiveness analysis is an essential component of informed debate about priority setting for HIV/AIDS.
Keywords
MedicineEconomics, Econometrics and Finance
World development report 1993 : investing in health
2,419 Citations1993Seth Berkley, Jose‐Luis Bobadilla +7 more
This report examines the controversial questions surrounding health care and health policy and advocates a threefold approach to health policy for governments in developing countries and in the formerly socialist countries, based in large part on innovative research.
JAMAThe Role of Cost-effectiveness Analysis in Health and Medicine
1,172 Citations1996Louise B. Russell
JAMAThe role of cost-effectiveness analysis in health and medicine. Panel on Cost-Effectiveness in Health and Medicine
975 Citations1996Louise B. Russell
The LancetProspects for worldwide tuberculosis control under the WHO DOTS strategy
468 Citations1998Christopher Dye, Geoffrey P. Garnett +2 more
An age-structured mathematical model is developed to explore the characteristics of tuberculosis control under DOTS, and to forecast the effect of improved case finding and cure on tuberculosis epidemics for each of the six WHO regions.
The LancetCost-effectiveness of voluntary HIV-1 counselling and testing in reducing sexual transmission of HIV-1 in Kenya and Tanzania
391 Citations2000Michael Sweat, Steven E. Gregorich +6 more
HIV-1 VCT is highly cost-effective in urban east African settings, but slightly less so than interventions such as improvement of sexually transmitted disease services and universal provision of nevirapine to pregnant women in high-prevalence settings.
Forum for Development StudiesWorld Development Report 1993: ‘Investing in Health’
265 Citations1993Rune Andreas Lea
The LancetCost effectiveness of single-dose nevirapine regimen for mothers and babies to decrease vertical HIV-1 transmission in sub-Saharan Africa
264 Citations1999Elliot Marseille, James G. Kahn +5 more
The cost effectiveness of HIVNET 012 was robust under a wide range of parameters in the sensitivity analysis, and in lower seroprevalence areas, when multidose regimens are not cost effective, nevirapine therapy could have a major public-health impact at a reasonable cost.
The LancetCost effectiveness of chemotherapy for pulmonary tuberculosis in three sub-Saharan African countries
192 Citations1991Christopher Murray, E. DeJonghe +4 more
Because the greatest benefit of chemotherapy is reduced transmission of the bacillus, treating HIV-seropositive, tuberculosis smear-positive patients would be only slightly less cost-effective than treatingAIDS-seronegative, tuberculosis-smear- positive patients.
The LancetCost-effectiveness of improved treatment services for sexually transmitted diseases in preventing HIV-1 infection in Mwanza Region, Tanzania
184 Citations1997Lucy Gilson, R. J. B. Mkanje +11 more
Improved management of STDs in rural health units reduced the incidence of HIV-1 infection in the general population by about 40% and the estimated cost-effectiveness compares favourably with that of, for example, childhood immunisation programmes.
Health Policy and PlanningThe real and the nominal? Making inflationary adjustments to cost and other economic data
150 Citations2000L. Kumaranayake
Methods to adjust cost data to account for inflation are looked at and the difference between real or constant and nominal or current values is discussed.
PubMedControlling HIV in Africa: effectiveness and cost of an intervention in a high-frequency STD transmitter core group.
135 Citations1991Stephen Moses, Frank Plummer +4 more
BMJComparison of cost effectiveness of directly observed treatment (DOT) and conventionally delivered treatment for tuberculosis: experience from rural South Africa
134 Citations1997Katherine Floyd, David Wilkinson +1 more
This study found that community based directly observed treatment, a novel approach to treating tuberculosis, was considerably cheaper and more cost effective than a conventional approach entailing prolonged admission to hospital.
BMJPrevention of vertical transmission of HIV: analysis of cost effectiveness of options available in South Africa
128 Citations1999N. Söderlund, Karen Zwi +2 more
Antiretroviral interventions are probably cost effective across a wide range of settings, with or without formula feeding interventions, and the appropriateness of formulafeeding was highly cost effective only in settings with high seroprevalence and reasonable levels of child survival and dangerous where infant mortality was high or the protective effect of breastfeeding substantial.
Health PolicyPublic spending on health care: how are different criteria related?
126 Citations1999Philip Musgrove
Properly thought-out choices of which health care interventions to finance with public funds depend not only on looking at all these criteria, but also on treating them in the appropriate sequence and taking account of their possible inconsistencies.
Transactions of the Royal Society of Tropical Medicine and HygieneThe impact of human immunodeficiency virus on mortality of patients treated for tuberculosis in a cohort study in Zambia
101 Citations1995Alison M. Elliott, B Halwiindi +9 more
Risk factors for death in HIV-positive patients included multi-site tuberculosis, history of prolonged diarrhoea or fever, oral thrush, splenomegaly, anergy to tuberculin, low weight, anaemia or lymphopenia, and poor compliance with regimens containing rifampicin and pyrazinamide.
The LancetExtent to which low-level use of antiretroviral treatment could curb the AIDS epidemic in sub-Saharan Africa
90 Citations2000Evan Wood, Paula Braitstein +5 more
Although there are barriers to widespread HIV-1 treatment, limited use of antiretrovirals could have an immediate and substantial impact on South Africa's AIDS epidemic.
AIDSControlling HIV in Africa
88 Citations1991Stephen Moses, Francis A. Plummer +4 more
It is estimated that theSTDVHIV control programme is responsible for preventing between 6000 and 10000 new cases of HIV infection per year among clients and contacts of clients and the total annual operating cost is approximately US$77000.
Transactions of the Royal Society of Tropical Medicine and HygieneTreatment outcome of an unselected cohort of tuberculosis patients in relation to human immunodeficiency virus serostatus in Zomba hospital, Malawi
81 Citations1998Anthony Harries, D.S. Nyangulu +9 more
National TB control programmes in areas of high HIV prevalence should no longer ignore treatment outcomes in patients with smear-negative PTB or EPTB, which have low treatment completion and high death rates, related to high levels of HIV infection.
PubMedCost-effectiveness of short-course zidovudine to prevent perinatal HIV type 1 infection in a sub-Saharan African Developing country setting.
71 Citations1996Gordon Mansergh, Anne C. Haddix +5 more
AIDSUsing cost-effectiveness league tables to compare interventions to prevent sexual transmission of HIV
70 Citations2001Steven D. Pinkerton, Ana P. Johnson‐Masotti +2 more
A common outcome measure for use in HIV prevention league tables is proposed and a preliminary league table of interventions to reduce sexual transmission of HIV in the US is presented, highlighting some of the difficulties associated with the league table approach.
Social Science & MedicineAn economic evaluation of alternative programme designs for tuberculosis control in rural Uganda
67 Citations1995Paul Saunderson
It is concluded that a programme based on the ambulatory treatment of patients at their nearest health unit, whilst living at home, is the most cost-effective design, largely because of reduced costs to the patients themselves.
AIDSTuberculosis preventive therapy for HIV-infected people in sub-Saharan Africa is cost-effective
66 Citations1999Jensa C. Bell, David N. Rose +1 more
TB preventive therapy taken by HIV-infected tuberculin reactors in sub-Saharan Africa results in extended life-expectancy, reduction of the incidence of TB and monetary savings in medical care and social costs.
AIDSCost-effectiveness of antiviral drug therapy to reduce mother-to-child HIV transmission in sub-Saharan Africa
65 Citations1998Elliot Marseille, James G. Kahn +1 more
Antiviral therapy may be cost-effective compared with other health interventions if HIV prevalence is high, if clinical trials confirm estimated efficacies, and if drug prices are reduced.
AIDS CareThe cost of home-based care for HIV/AIDS patients in Zimbabwe
60 Citations1998Kristian Schultz Hansen, Godfrey Woelk +7 more
The programme costs are high, and schemes do not generally assess effectiveness, nor cost-effectiveness, leaving a larger part of both the burden and the cost of care to the families and the patients.
AIDSAntiretroviral drugs as a public health intervention for pregnant HIV-infected women in rural South Africa
56 Citations1998David Wilkinson, Katherine Floyd +1 more
Although antiretrovirals may be relatively cost-effective in this setting, the budget required is currently unaffordable and developing the capacity required to deliver the intervention would pose both a major challenge, and an opportunity, to improve health services.
The LancetBenefits of HIV screening of blood transfusions in Zambia
49 Citations1995S. Catherine Foster, Anne Buvé
The costs of screening transfusions for HIV and the financial benefits in terms of savings on treatment costs averted were calculated for a district hospital in Zambia where seroprevalence among donors was 15.9%.
PubMedMeasurement and determinants of tuberculosis outcome in Karonga District, Malawi.
44 Citations1998Judith R. Glynn, David K Warndorff +4 more
Examination of factors influencing the measurement of outcome, survival rates during and after treatment, smear conversion rates, and relapse rates for patients diagnosed with TB in a rural area of Malawi between 1986 and mid-1994 found patients with less certain diagnoses of TB were more likely to die.
PubMedNational and provincial estimated costs and cost effectiveness of a programme to reduce mother-to-child HIV transmission in South Africa.
42 Citations2000David Wilkinson, Katherine Floyd +1 more
A national programme preventing 37% of expected paediatric HIV infections would cost a small fraction of the national health budget, at a cost equivalent to R3.89 per capita total population, and compares well with established public health and clinical interventions in middle-income countries.
AIDSCost-effectiveness and cost-benefit in the prevention of mother-to-child transmission of HIV in developing countries
40 Citations1998Marie‐Louise Newell, François Dabis +2 more
JAIDS Journal of Acquired Immune Deficiency SyndromesCost-Effective Use of Nevirapine to Prevent Vertical HIV Transmission in Sub-Saharan Africa
39 Citations2000Jeffrey S. A. Stringer, Dwight J. Rouse +4 more
Clinical assessment of adherence to therapy among women who do not know their status and the field effectiveness of alternative approaches to NVP administration is urgently needed to allow identification of optimal prevention strategies.
JAMACost-effectiveness of Short-Course Zidovudine to Prevent Perinatal HIV Type 1 Infection in a Sub-Saharan African Developing Country Setting
37 Citations1996Gordon Mansergh
A national perinatal HIV prevention program with zidovudine in most sub-Saharan African country settings would reduce the incidence of infant HIV infection and, in some settings, provide societal savings; however, substantial initial investment in such programs will be required.
Health Policy and PlanningFeasibility of Hospital-Based Blood Banking: A Tanzanian Case Study
33 Citations1999Bart Jacobs, Andrew A. Mercer
It is argued here that hospital-based blood transfusion services operating at a basic adequate level are sufficient for low-income African countries and safe blood transfusions practices can be assured at an annual cost of US$0.07 per capita.
PubMedSystematic review on the cost-effectiveness of public health interventions for HIV prevention in industrialized countries.
28 Citations1998Matthias Schrappe, Karl W. Lauterbach
The British Medical Journal guidelines for economic analysis in medicine are a feasible instrument for systematic reviews of cost-effectiveness studies on primary HIV infection and a clear definition of outcome parameters as an object of economic evaluation can be regarded as crucial.
PubMedDeferral of blood donors with risk factors for HIV infection saves lives and money in Zimbabwe.
23 Citations1995Willi McFarland, Kahn Jg +3 more
The Defer/Test strategy is cost-effective in Zimbabwe because additional recruitment costs are offset by discarding fewer HIV-positive units and the number of false negatives is lower with a lower HIV prevalence among accepted donors.
The International Journal of Health Planning and ManagementCost‐effectiveness of chemotherapy for sputum smear‐positive pulmonary tuberculosis in Malawi, Mozambique and Tanzania
22 Citations1994Eric De Jonghe, Christopher J L Murray +4 more
The cost-effectiveness of chemotherapy for pulmonary sputum smear-positive tuberculosis was examined in the national tuberculosis control programmes of Malawi, Mozambique and Tanzania and found that in all conditions, short-course chemotherapy is preferable to standard 12-month chemotherapy.
AIDSFighting global AIDS: the value of cost-effectiveness analysis
13 Citations2000James G. Kahn, Elliot Marseille
The authors propose that cost-effectiveness analysts direct a larger portion of their efforts to Africa and other needy settings and recognize the evidence of public health efficacy gathered from most affected regions of HIV/AIDS epidemic.